1-Methyl-4-(8-(1-methyl-1H-tetrazol-5-yl)-10,11-dihydrodibenzo[b,f]thiepin-10-yl)piperazine

ID: ALA1259217

PubChem CID: 49781233

Max Phase: Preclinical

Molecular Formula: C21H24N6S

Molecular Weight: 392.53

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CCN(C2Cc3ccccc3Sc3ccc(-c4nnnn4C)cc32)CC1

Standard InChI:  InChI=1S/C21H24N6S/c1-25-9-11-27(12-10-25)18-14-15-5-3-4-6-19(15)28-20-8-7-16(13-17(18)20)21-22-23-24-26(21)2/h3-8,13,18H,9-12,14H2,1-2H3

Standard InChI Key:  NHCPMAKOQMYGRA-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 32  0  0  0  0  0  0  0  0999 V2000
   -1.3616    0.9439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5574    0.7427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3971   -0.9167    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0152   -0.3926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0258    0.4073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7226    0.7964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4094    0.3867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3949   -0.4162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6976   -0.8016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2245   -0.0046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6189   -0.7672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1559   -1.4879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7015   -1.4472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0937   -0.6798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6284    0.0377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5394    1.7495    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9276    2.3036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1027    3.1061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8883    3.3591    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4992    2.8031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3244    1.9941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0631    4.1680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1304    0.7876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1210    1.6089    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9010    1.8777    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3976    1.2189    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9244    0.5431    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1922   -0.2373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  6  1  0
 13 14  1  0
 11  3  1  0
 14 15  2  0
 15 10  1  0
  6  7  2  0
  1 16  1  0
 16 17  1  0
  3  4  1  0
  7  8  1  0
  2 10  1  0
  8  9  2  0
  9  4  1  0
 16 21  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 19 22  1  0
  1  5  1  0
  7 23  1  0
 23 24  2  0
 10 11  2  0
  4  5  2  0
 11 12  1  0
  1  2  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 23  1  0
 12 13  2  0
 27 28  1  0
M  END

Associated Targets(Human)

DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ADRA1A Alpha-1a adrenergic receptor (303 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1B Alpha-1b adrenergic receptor (201 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1d Alpha-1d adrenergic receptor (1475 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 392.53Molecular Weight (Monoisotopic): 392.1783AlogP: 2.87#Rotatable Bonds: 2
Polar Surface Area: 50.08Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.98CX LogP: 3.45CX LogD: 2.77
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.67Np Likeness Score: -1.23

References

1. Kristensen JL, Püschl A, Jensen M, Risgaard R, Christoffersen CT, Bang-Andersen B, Balle T..  (2010)  Exploring the neuroleptic substituent in octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for α(1)-adrenoceptors.,  53  (19): [PMID:20857909] [10.1021/jm100652h]

Source